Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD)(U01 Clinical Trial Optional)

From US Department of Health & Human Services: National Institutes of Health (NIH)

The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

Type of Support

Overview

The grant program encourages prospective applicants to submit a Letter of Interest by a specific date, although it's not a requirement for application. It follows a series of deadlines for standard grant applications, with a clear schedule spanning from November 3, 2023, to February 5, 2026. Each application must be submitted by 5:00 pm local time of the applicant organization. This implies a structured, recurring opportunity for funding across multiple years, accommodating various project timelines and planning phases.

Eligibility

Organization's Location
USA, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, British Virgin Islands
Program Location
USA, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands
Organization Type
not specified

Submission

Visit Apply for more information.

Similar grants